MAGNA MANIPULACAO E HOMEOPATIA
⚠️ High Risk
FEI: 3026648660 • Rio De Janeiro, Rio de Janeiro • BRAZIL
FEI Number
3026648660
Location
Rio De Janeiro, Rio de Janeiro
Country
BRAZILAddress
Avenida Das Americas 500 Bl, , Rio De Janeiro, Rio de Janeiro, Brazil
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/4/2023 | 61NCA60TRAZODONE HCL (ANTI-DEPRESSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 64RCA99HORMONE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 61MCA40TOPIRAMATE (ANTI-CONVULSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 65VCA99SEDATIVE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 54FFA99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 60RCA19SIBUTRAMINE HCL MONOHYDRATE (ANOREXIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 62ICA85LETROZOLE (ANTI-NEOPLASTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 64UCA08DUTASTERIDE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 64BCA37SPIRONOLACTONE (DIURETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 60RCA18ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 61NCA83ESCITALOPRAM OXALATE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 61NCA05BUPROPION HCL (ANTI-DEPRESSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 60TCA15NALTREXONE (ANTAGONIST) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 65CCA04BETAINE ANHYDROUS (NUTRIENT/TONIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 62TCA07PANTOPRAZOLE SODIUM | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/4/2023 | 61PCA26METFORMIN (ANTI-DIABETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is MAGNA MANIPULACAO E HOMEOPATIA's FDA import refusal history?
MAGNA MANIPULACAO E HOMEOPATIA (FEI: 3026648660) has 17 FDA import refusal record(s) in our database, spanning from 12/4/2023 to 12/4/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. MAGNA MANIPULACAO E HOMEOPATIA's FEI number is 3026648660.
What types of violations has MAGNA MANIPULACAO E HOMEOPATIA received?
MAGNA MANIPULACAO E HOMEOPATIA has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about MAGNA MANIPULACAO E HOMEOPATIA come from?
All FDA import refusal data for MAGNA MANIPULACAO E HOMEOPATIA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.